FACIT logo

FACIT

North America, Ontario, Canada, Toronto

Description

FACIT is designed to support early stage proof-of-concept (POC) studies within Ontario academic institutions.

Investor Profile

FACIT has backed more than 8 startups, with 4 new investments in the last 12 months alone. The firm has led 1 rounds, about 13% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in Canada, United States.
  • Strong thematic focus on Biotechnology, Medical, Therapeutics.
  • Led 1 rounds in the past year.

Stage Focus

  • Seed (50%)
  • Series B (25%)
  • Series A (25%)

Country Focus

  • Canada (75%)
  • United States (25%)

Industry Focus

  • Biotechnology
  • Medical
  • Therapeutics
  • Life Science
  • Biopharma
  • Pharmaceutical
  • Innovation Management
  • Health Care
  • Oncology
  • Home Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does FACIT frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Genesys Capital
North America, Ontario, Canada, Toronto
Co-Investments: 1
Toronto Innovation Acceleration Partners
North America, Ontario, Canada, Toronto
Co-Investments: 2
Adams Street Partners
North America, Illinois, United States, Chicago
Co-Investments: 1
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 1
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1
Pivotal bioVenture Partners
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by FACIT?

Esphera SynBio

Ottawa, Ontario, Canada

Esphera SynBio operates as a biotechnology company.

BiotechnologyLife ScienceMedical
SeedJan 7, 2025
Amount Raised: $2,000,000
Hyivy Health

Kitchener, Ontario, Canada

HyIvy Health offers a pelvic rehabilitation device with trackable data for women recovering from pelvic diseases and surgeries.

Health CareHome Health CareMedicalMedical DevicemHealthPersonal HealthRehabilitation
SeedSep 24, 2024
Amount Raised: $1,490,219
Radiant Biotherapeutics

Toronto, Ontario, Canada

Radiant is a biotechnology company developing the next generation of multi-specificity.

BiotechnologyTherapeutics
Series ASep 11, 2024
Amount Raised: $35,000,000
HDAX Therapeutics

Toronto, Ontario, Canada

HDAC6, small molecule, peripheral neuropathy, cardiometabolic, pharmaceuticals, biotech, biopharma, life science

BiopharmaBiotechnologyLife SciencePharmaceutical
SeedSep 5, 2024
Amount Raised: $3,185,067
CTRL Therapeutics

Toronto, Ontario, Canada

CTRL Therapeutics operates a biotechnology company that researches cell therapy and treatment.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
SeedApr 10, 2023
Amount Raised: $10,000,000
Fusion Pharmaceuticals

Hamilton, Ontario, Canada

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

BiopharmaBiotechnologyMedicalOncologyPharmaceutical
Series BApr 1, 2019
Amount Raised: $105,000,000
Turnstone Biologics

La Jolla, California, United States

Turnstone Biologics is a privately-held clinical stage biotech company.

BiotechnologyInnovation ManagementTherapeutics
Series BNov 2, 2016
Amount Raised: $41,400,000
Turnstone Biologics

La Jolla, California, United States

Turnstone Biologics is a privately-held clinical stage biotech company.

BiotechnologyInnovation ManagementTherapeutics
Series AOct 27, 2015
Amount Raised: $11,300,000